Details of the Drug Reposition

General Information of This Drug (ID: DMAC130)

Drug Name
Inotuzumab ozogamicin   DMAC130
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphoblastic leukaemia DIS87TGM 2A85 Approved [1]
Acute lymphocytic leukaemia DISPX75S 2B33.3 Approved [2]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8266).
2 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.